Global Oligonucleotide Therapeutics Market 2020-2024

Global Oligonucleotide Therapeutics Market 2020-2024

Technavio has been monitoring the oligonucleotide therapeutics market, and it is poised to grow by USD 901.18 mn during 2020-2024

, progressing at a CAGR of 10% during the forecast period. Our reports on oligonucleotide therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing incidence of cancer and the need for personalized medicines for neurodegenerative disorders.

The oligonucleotide therapeutics market analysis includes segments as application, technology, and geographic landscape.

Technavio's oligonucleotide therapeutics market is segmented as below:

By Application Neurological disorders Cancer Others By Technology Antisense/RNAi oligonucleotides Others By Geographic Landscapes North America Europe APAC South America MEA

This study identifies the increased availability of approved drugs as one of the prime reasons driving the oligonucleotide therapeutics market growth during the next few years.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of critical parameters. Our oligonucleotide therapeutics market covers the following areas:

Oligonucleotide therapeutics market sizing Oligonucleotide therapeutics market forecast Oligonucleotide therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position. In line with this, this report provides a detailed analysis of several leading oligonucleotide therapeutics market vendors that include Alnylam Pharmaceuticals Inc., Arrowhead Pharmaceuticals Inc., Biogen Inc., Dynavax Technologies Corp., GlaxoSmithKline Plc, Ionis Pharmaceuticals Inc., Merck & Co. Inc., Miragen Therapeutics Inc., PCI Biotech Holding ASA, and Sarepta Therapeutics Inc. Also, the oligonucleotide therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information, including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources by an analysis of critical parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market characteristics
    • Value chain analysis
  • Market Sizing
    • Market definition
      • Table Product / Service portfolio of key vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2019
    • Market outlook: Forecast for 2019 - 2024
      • Table Global - Market size and forecast 2019 - 2024 ($ million)
      • Table Global market: Year-over-year growth 2019 - 2024 (%)
  • Five Forces Analysis
    • Five Forces Summary
      • Table Five forces analysis 2019 & 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market Segmentation by Application
    • Market segments
      • Table Application - Market share 2019-2024 (%)
    • Comparison by Application
      • Table Comparison by Application
    • Neurological disorders - Market size and forecast 2019-2024
      • Table Neurological disorders - Market size and forecast 2019-2024 ($ million)
      • Table Neurological disorders - Year-over-year growth 2019-2024 (%)
    • Cancer - Market size and forecast 2019-2024
      • Table Cancer - Market size and forecast 2019-2024 ($ million)
      • Table Cancer - Year-over-year growth 2019-2024 (%)
    • Others - Market size and forecast 2019-2024
      • Table Others - Market size and forecast 2019-2024 ($ million)
      • Table Others - Year-over-year growth 2019-2024 (%)
    • Market opportunity by Application
      • Table Market opportunity by Application
  • Market Segmentation by Technology
    • Market segments
      • Table Technology - Market share 2019-2024 (%)
    • Comparison by Technology
      • Table Comparison by Technology
    • Antisense/RNAi oligonucleotides - Market size and forecast 2019-2024
      • Table Antisense/RNAi oligonucleotides - Market size and forecast 2019-2024 ($ million)
      • Table Antisense/RNAi oligonucleotides - Year-over-year growth 2019-2024 (%)
    • Others - Market size and forecast 2019-2024
      • Table Others - Market size and forecast 2019-2024 ($ million)
      • Table Others - Year-over-year growth 2019-2024 (%)
    • Market opportunity by Technology
      • Table Market opportunity by Technology
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • Geographic comparison
      • Table Geographic comparison
    • North America - Market size and forecast 2019- 2024
      • Table North America - Market size and forecast 2019-2024 ($ million)
      • Table North America - Year-over-year growth 2019-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ million)
      • Table Europe - Year-over-year growth 2019-2024 (%)
    • APAC - Market size and forecast 2019-2024
      • Table APAC - Market size and forecast 2019-2024 ($ million)
      • Table APAC - Year-over-year growth 2019-2024 (%)
    • South America - Market size and forecast 2019- 2024
      • Table South America - Market size and forecast 2019-2024 ($ million)
      • Table South America - Year-over-year growth 2019-2024 (%)
    • MEA - Market size and forecast 2019-2024
      • Table MEA - Market size and forecast 2019-2024 ($ million)
      • Table MEA - Year-over-year growth 2019-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography
  • Drivers, Challenges, and Trends
    • Volume driver - Demand led growth
      • Increasing incidence of cancer boosts demand for novel diagnostics
      • Need for personalized medicines for neurodegenerative disorders
    • Volume driver - Supply led growth
      • Increased availability of approved drugs
    • Market challenges
      • Toxicity of Antisense and RNAi molecule-based drugs
      • Inherent challenges associated with oligonucleotide therapies
      • Instability of RNAi and Antisense molecules
        • Table Impact of drivers and challenges
    • Market trends
      • Increasing strategic collaborations
      • Advances in DNA sequencing increases use of microfluidic techniques
      • Increasing drugs in pipeline
  • Vendor Landscape
    • Table Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Alnylam Pharmaceuticals Inc.
      • Table Alnylam Pharmaceuticals Inc. - Overview
      • Table Alnylam Pharmaceuticals Inc. - Business segments
      • Table Alnylam Pharmaceuticals Inc.- Key news
      • Table Alnylam Pharmaceuticals Inc. - Key offerings
    • Arrowhead Pharmaceuticals Inc.
      • Table Arrowhead Pharmaceuticals Inc. - Overview
      • Table Arrowhead Pharmaceuticals Inc. - Business segments
      • Table Arrowhead Pharmaceuticals Inc.- Key news
      • Table Arrowhead Pharmaceuticals Inc. - Key offerings
    • Biogen Inc.
      • Table Biogen Inc. - Overview
      • Table Biogen Inc. - Business segments
      • Table Biogen Inc.- Key news
      • Table Biogen Inc. - Key offerings
    • Dynavax Technologies Corp.
      • Table Dynavax Technologies Corp. - Overview
      • Table Dynavax Technologies Corp. - Business segments
      • Table Dynavax Technologies Corp.- Key news
      • Table Dynavax Technologies Corp. - Key offerings
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc- Key news
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc - Segment focus
    • Ionis Pharmaceuticals Inc.
      • Table Ionis Pharmaceuticals Inc. - Overview
      • Table Ionis Pharmaceuticals Inc. - Business segments
      • Table Ionis Pharmaceuticals Inc.- Key news
      • Table Ionis Pharmaceuticals Inc. - Key offerings
      • Table Ionis Pharmaceuticals Inc. - Segment focus
    • Merck & Co. Inc.
      • Table Merck & Co. Inc. - Overview
      • Table Merck & Co. Inc. - Business segments
      • Table Merck & Co., Inc.- Key news
      • Table Merck & Co. Inc. - Key offerings
      • Table Merck & Co. Inc. - Segment focus
    • Miragen Therapeutics Inc.
      • Table Miragen Therapeutics Inc. - Overview
      • Table Miragen Therapeutics Inc. - Business segments
      • Table Miragen Therapeutics Inc. - Key offerings
    • PCI Biotech Holding ASA
      • Table PCI Biotech Holding ASA - Overview
      • Table PCI Biotech Holding ASA - Business segments
      • Table PCI Biotech Holding ASA - Key offerings
      • Table PCI Biotech Holding ASA- Key news
    • Sarepta Therapeutics Inc.
      • Table Sarepta Therapeutics Inc. - Overview
      • Table Sarepta Therapeutics Inc. - Business segments
      • Table Sarepta Therapeutics- Key news
      • Table Sarepta Therapeutics Inc. - Key offerings
  • Appendix
    • Scope of the report
      • Market definition
      • Objectives
      • Notes and caveats
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook